192 related articles for article (PubMed ID: 38478333)
21. The connection between the Th17 cell related cytokines and cancer stem cells in cancer: Novel therapeutic targets.
Shahid A; Bharadwaj M
Immunol Lett; 2019 Sep; 213():9-20. PubMed ID: 31278971
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
23. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
Chen K; Huang YH; Chen JL
Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
[TBL] [Abstract][Full Text] [Related]
24. PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.
Parte S; Virant-Klun I; Patankar M; Batra SK; Straughn A; Kakar SS
Stem Cell Rev Rep; 2019 Dec; 15(6):866-879. PubMed ID: 31482269
[TBL] [Abstract][Full Text] [Related]
25. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function.
Chowdhury FN; Reisinger J; Gomez KE; Chimed TS; Thomas CM; Le PN; Miller B; Morton JJ; Nieto CM; Somerset HL; Wang XJ; Keysar SB; Jimeno A
Oral Oncol; 2019 Nov; 98():118-124. PubMed ID: 31586893
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance.
Verma P; Shukla N; Kumari S; Ansari MS; Gautam NK; Patel GK
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188887. PubMed ID: 36997008
[TBL] [Abstract][Full Text] [Related]
27. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf.
Dzobo K; Senthebane DA; Rowe A; Thomford NE; Mwapagha LM; Al-Awwad N; Dandara C; Parker MI
OMICS; 2016 Dec; 20(12):681-691. PubMed ID: 27930094
[TBL] [Abstract][Full Text] [Related]
28. Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres.
Mehta P; Novak C; Raghavan S; Ward M; Mehta G
Methods Mol Biol; 2018; 1692():61-75. PubMed ID: 28986887
[TBL] [Abstract][Full Text] [Related]
29. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells.
Vaz AP; Ponnusamy MP; Rachagani S; Dey P; Ganti AK; Batra SK
Br J Cancer; 2014 Jul; 111(3):486-96. PubMed ID: 25003666
[TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.
Makena MR; Ranjan A; Thirumala V; Reddy AP
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165339. PubMed ID: 30481586
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
De Francesco EM; Sotgia F; Lisanti MP
Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
[TBL] [Abstract][Full Text] [Related]
32. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
34. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.
Kim JK; Jeon HY; Kim H
Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807
[TBL] [Abstract][Full Text] [Related]
35. Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination.
Barati M; Akhondi M; Mousavi NS; Haghparast N; Ghodsi A; Baharvand H; Ebrahimi M; Hassani SN
Stem Cell Rev Rep; 2021 Dec; 17(6):1975-1992. PubMed ID: 34115316
[TBL] [Abstract][Full Text] [Related]
36. The strategies to cure cancer patients by eradicating cancer stem-like cells.
Mai Y; Su J; Yang C; Xia C; Fu L
Mol Cancer; 2023 Oct; 22(1):171. PubMed ID: 37853413
[TBL] [Abstract][Full Text] [Related]
37. Principles and Methods of Immunohistochemistry.
Ramos-Vara JA
Methods Mol Biol; 2017; 1641():115-128. PubMed ID: 28748460
[TBL] [Abstract][Full Text] [Related]
38. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
39. Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
Dzobo K; Ganz C; Thomford NE; Senthebane DA
OMICS; 2021 Feb; 25(2):81-92. PubMed ID: 33170084
[TBL] [Abstract][Full Text] [Related]
40. Cancer cells stemness: A doorstep to targeted therapy.
Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]